[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IE46005B1 - Preparations of 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoic acid and process for their manufacture - Google Patents

Preparations of 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoic acid and process for their manufacture

Info

Publication number
IE46005B1
IE46005B1 IE2474/77A IE247477A IE46005B1 IE 46005 B1 IE46005 B1 IE 46005B1 IE 2474/77 A IE2474/77 A IE 2474/77A IE 247477 A IE247477 A IE 247477A IE 46005 B1 IE46005 B1 IE 46005B1
Authority
IE
Ireland
Prior art keywords
particles
active substance
pharmaceutical preparation
coating
coated
Prior art date
Application number
IE2474/77A
Other languages
English (en)
Other versions
IE46005L (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IE46005L publication Critical patent/IE46005L/xx
Publication of IE46005B1 publication Critical patent/IE46005B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IE2474/77A 1976-12-07 1977-12-06 Preparations of 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoic acid and process for their manufacture IE46005B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762655331 DE2655331A1 (de) 1976-12-07 1976-12-07 Zubereitungsformen von 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoesaeure und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
IE46005L IE46005L (en) 1978-06-07
IE46005B1 true IE46005B1 (en) 1983-01-26

Family

ID=5994862

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2474/77A IE46005B1 (en) 1976-12-07 1977-12-06 Preparations of 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoic acid and process for their manufacture

Country Status (15)

Country Link
JP (1) JPS5372815A (de)
AT (1) AT355216B (de)
AU (1) AU513409B2 (de)
BE (1) BE861608A (de)
DE (1) DE2655331A1 (de)
DK (1) DK542877A (de)
ES (1) ES464642A1 (de)
FR (1) FR2373280A1 (de)
GB (1) GB1569018A (de)
IE (1) IE46005B1 (de)
IL (1) IL53539A0 (de)
NL (1) NL7713392A (de)
NZ (1) NZ185855A (de)
PT (1) PT67370B (de)
ZA (1) ZA777204B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE66157T1 (de) * 1986-04-29 1991-08-15 Hoechst Roussel Pharma Schichtenstruktur fuer die verabreichung von chemikalien mit kontrollierter abgaberate.
SE460947B (sv) * 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa
ATE194607T1 (de) * 1995-02-22 2000-07-15 Hoechst Japan Amorph piretanide, polymorphe davon, verfahren zur dessen herstellung und ihre verwendung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE33874B1 (en) * 1968-12-24 1974-11-27 Leo Pharm Prod Ltd New sulphamyl-benzoic acid derivatives

Also Published As

Publication number Publication date
FR2373280A1 (fr) 1978-07-07
PT67370B (de) 1979-09-20
NL7713392A (nl) 1978-06-09
GB1569018A (en) 1980-06-11
FR2373280B1 (de) 1980-06-20
JPS5372815A (en) 1978-06-28
DE2655331A1 (de) 1978-06-08
DK542877A (da) 1978-06-08
ES464642A1 (es) 1978-09-01
PT67370A (de) 1978-01-01
IL53539A0 (en) 1978-03-10
ZA777204B (en) 1978-10-25
AU3127477A (en) 1979-06-14
AT355216B (de) 1980-02-25
ATA873777A (de) 1979-07-15
IE46005L (en) 1978-06-07
NZ185855A (en) 1979-10-25
AU513409B2 (en) 1980-11-27
BE861608A (fr) 1978-06-07

Similar Documents

Publication Publication Date Title
US4083949A (en) New oral form of medicament and a method for producing it
US3773920A (en) Sustained release medicinal composition
US5370880A (en) Pharmaceutical formulations containing acrivastine
CA2281420C (en) Preparation of pharmaceutically-active granules
AU709887B2 (en) Long-lasting release Nifedipine preparation
JP2535339B2 (ja) 活性物質の制御速度制御用装置
US4533540A (en) Nitroglycerin-containing polymeric matrix for sustained release on topical application
US3074852A (en) Pharmaceuticals with delayed release
US4721619A (en) Controlled absorption diltiazen pharmaceutical formulation
CA2265766C (en) Rapidly disintegrating pellets
JP3157182B2 (ja) 一日一回投与のための吸収の制御されたナプロキセン配合物
US4806361A (en) Medicaments in sustained release unit dose form
US5275825A (en) Compressed-molded preparations
AU592731B2 (en) Nitrofurantoin dosage form
JPS6323814A (ja) 経口投与形体の徐放性医薬組成物
JPH06503311A (ja) 薬理学的に活性なイオン化可能物質を含有する新規な医薬製剤およびその製造法
CA1261268A (en) Theophylline sustained release formulation
CA1184497A (en) Pharmaceutical composition
JPH0764725B2 (ja) 徐放性錠剤およびその製造方法
GB1593062A (en) Coatings
KR890006240A (ko) 조절흡수 딜티아젬 제제
Karvekar et al. A brief review on sustained release matrix type drug delivery system
IE46005B1 (en) Preparations of 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoic acid and process for their manufacture
US5230901A (en) Sustained release tablet of a mixture of alginates and polyacrylates
RU2435584C2 (ru) Пролонгированная фармацевтическая композиция, лекарственная форма и способ ее изготовления (варианты)